180 Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ATNF Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
15 Dec 23	BuyUS$4,700	James Woody	Individual		1,315.79	US$3.57
15 Dec 23	SellUS$4,700	Marc Feldman	Individual		1,315.79	US$3.57

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 161%.

Top 13 shareholders own 16.05% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.87%	Marc Feldman	70,532	US$158.7k	434%	no data
5.7%	Armistice Capital LLC	58,552	US$131.7k	0%	no data
1.37%	Virtu Financial LLC, Asset Management Arm	14,088	US$31.7k	0%	no data
0.67%	UBS Asset Management AG	6,847	US$15.4k	0%	no data
0.48%	Geode Capital Management, LLC	4,915	US$11.1k	-0.28%	no data
0.25%	Lawrence Steinman	2,535	US$5.7k	0.04%	no data
0.25%	The Vanguard Group, Inc.	2,521	US$5.7k	0%	no data
0.23%	Tower Research Capital Europe Limited	2,335	US$5.3k	-62.8%	no data
0.14%	Jonathan Rothbard	1,475	US$3.3k	0%	no data
0.055%	BlackRock, Inc.	564	US$1.3k	-26.9%	no data
0.046%	Ozan Pamir	474	US$1.1k	0.21%	no data
0.00068%	Bank of America Corporation, Asset Management Arm	7	US$15.7	-41.7%	no data
0.0001%	Semmax Financial Advisors, Inc, Asset Management Arm	1	US$2.3	0%	no data